AP3B2 p.Thr1100Ser

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_001278512.2(AP3B2):​c.3298A>T​(p.Thr1100Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T1100I) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)

Consequence

AP3B2
NM_001278512.2 missense

Scores

1
18

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.49

Publications

0 publications found
Variant links:
Genes affected
AP3B2 (HGNC:567): (adaptor related protein complex 3 subunit beta 2) Adaptor protein complex 3 (AP-3 complex) is a heterotrimeric protein complex involved in the formation of clathrin-coated synaptic vesicles. The protein encoded by this gene represents the beta subunit of the neuron-specific AP-3 complex and was first identified as the target antigen in human paraneoplastic neurologic disorders. The encoded subunit binds clathrin and is phosphorylated by a casein kinase-like protein, which mediates synaptic vesicle coat assembly. Defects in this gene are a cause of early-onset epileptic encephalopathy. [provided by RefSeq, Feb 2017]
CPEB1-AS1 (HGNC:27523): (CPEB1 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.058875114).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001278512.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AP3B2
NM_001278512.2
MANE Select
c.3298A>Tp.Thr1100Ser
missense
Exon 27 of 27NP_001265441.1Q13367-4
AP3B2
NM_004644.5
c.3241A>Tp.Thr1081Ser
missense
Exon 26 of 26NP_004635.2
AP3B2
NM_001278511.2
c.3145A>Tp.Thr1049Ser
missense
Exon 25 of 25NP_001265440.1Q13367-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AP3B2
ENST00000535359.6
TSL:1 MANE Select
c.3298A>Tp.Thr1100Ser
missense
Exon 27 of 27ENSP00000440984.1Q13367-4
AP3B2
ENST00000261722.8
TSL:1
c.3259A>Tp.Thr1087Ser
missense
Exon 26 of 26ENSP00000261722.4A0A5F9UJV3
AP3B2
ENST00000535348.5
TSL:1
c.3145A>Tp.Thr1049Ser
missense
Exon 25 of 25ENSP00000438721.1Q13367-3

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
32

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.072
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.62
CADD
Benign
18
DANN
Benign
0.93
DEOGEN2
Benign
0.068
T
Eigen
Benign
-0.68
Eigen_PC
Benign
-0.53
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Benign
0.58
T
M_CAP
Benign
0.023
T
MetaRNN
Benign
0.059
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.37
N
PhyloP100
1.5
PrimateAI
Benign
0.48
T
PROVEAN
Benign
0.030
N
REVEL
Benign
0.078
Sift
Benign
0.89
T
Sift4G
Benign
1.0
T
Varity_R
0.044
gMVP
0.093

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

hg19: chr15-83328320; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.